AURA AURA BIOSCIENCES INC revenue, earnings and financials
For the quarter ended June 30, 2026, AURA BIOSCIENCES INC reported revenue of n/a, net income of −$45.6M and diluted EPS of −$0.48; for the fiscal year ended December 2025 revenue was n/a.
AURA annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$113M, net income −$106M (margin n/a), EPS −$1.76
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$96.1M, net income −$86.9M (margin n/a), EPS −$1.75
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$85.0M, net income −$76.4M (margin n/a), EPS −$1.93
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$60.3M, net income −$58.8M (margin n/a), EPS −$1.96
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$35.3M, net income −$35.3M (margin n/a), EPS −$8.95
AURA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$45.6M, EPS −$0.48
- Quarter ended Mar 31, 2026: revenue n/a, net income −$33.7M, EPS −$0.50
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$25.6M, EPS −$0.34
- Quarter ended Sep 30, 2025: revenue n/a, net income −$26.1M, EPS −$0.40
- Quarter ended Jun 30, 2025: revenue n/a, net income −$27.0M, EPS −$0.47
- Quarter ended Mar 31, 2025: revenue n/a, net income −$27.5M, EPS −$0.55
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$25.8M, EPS −$0.52
- Quarter ended Sep 30, 2024: revenue n/a, net income −$21.0M, EPS −$0.42
- Quarter ended Jun 30, 2024: revenue n/a, net income −$20.3M, EPS −$0.41
- Quarter ended Mar 31, 2024: revenue n/a, net income −$19.7M, EPS −$0.40
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$22.1M, EPS −$0.51
- Quarter ended Sep 30, 2023: revenue n/a, net income −$18.5M, EPS −$0.48
- Quarter ended Jun 30, 2023: revenue n/a, net income −$18.3M, EPS −$0.48
- Quarter ended Mar 31, 2023: revenue n/a, net income −$17.5M, EPS −$0.46
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$16.6M, EPS −$0.52
- Quarter ended Sep 30, 2022: revenue n/a, net income −$15.9M, EPS −$0.54
- Quarter ended Jun 30, 2022: revenue n/a, net income −$13.5M, EPS −$0.46
- Quarter ended Mar 31, 2022: revenue n/a, net income −$12.8M, EPS −$0.44
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$11.6M, EPS $68.53
- Quarter ended Sep 30, 2021: revenue n/a, net income −$8.84M, EPS −$28.33
AURA cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$84.7M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$79.8M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$63.8M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$54.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$32.4M, share buybacks n/a
AURA balance sheet
- Jun 30, 2026: cash $67.8M, total assets $348M, total liabilities $32.9M, shareholders' equity $315M
- Mar 31, 2026: cash $84.8M, total assets $138M, total liabilities $30.4M, shareholders' equity $107M
- Dec 31, 2025: cash $59.5M, total assets $169M, total liabilities $32.5M, shareholders' equity $137M
- Sep 30, 2025: cash $47.6M, total assets $190M, total liabilities $33.4M, shareholders' equity $157M
- Jun 30, 2025: cash $107M, total assets $204M, total liabilities $29.8M, shareholders' equity $175M
- Mar 31, 2025: cash $38.2M, total assets $155M, total liabilities $27.4M, shareholders' equity $128M
- Dec 31, 2024: cash $31.7M, total assets $183M, total liabilities $30.5M, shareholders' equity $152M
- Sep 30, 2024: cash $25.4M, total assets $205M, total liabilities $30.7M, shareholders' equity $175M
Is AURA profitable?
No. AURA BIOSCIENCES INC lost $131M over the last four quarters.
What is AURA's EPS?
Diluted earnings per share over the last four quarters were −$1.72; −$0.48 in the latest quarter.